Bizarre Patents
A method of swing on a swing is disclosed, in which a user positioned on a standard swing suspended by two chains from a substantially horizontal tree branch induces side to side motion by pulling alternately on one chain and then the other.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5604260 | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 The Compound of Formula I and pharmaceutically acceptable salts thereof in the treatment of cyclooxygenase-2 mediated diseases are disclosed.... | 02/18/1997 |
| 5591775 | Trisubstituted naphthylalkylamides for disorders of the melatoninergic system The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R1, R2 and R3 are as defined herein for use in the treatment of a disorder of the melatoninergic system.... | 01/07/1997 |
| 5565478 | Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of formula I defined herein in combination with paclitaxel or other modified taxane analogs provide enhanced anticancer effects over the eff... | 10/15/1996 |
| 5559148 | Parenteral busulfan for treatment of malignant disease Stable parenteral formulations of busulfan for parenteral administration are disclosed. The improved bioavailability of the parenteral formulations optimizes high dose busulfan therapy against malignant disease and improves the safety of such therapy.... | 09/24/1996 |
| 5554650 | Antiphlogistic, analgesic, antipyretic injection preparation An antiphlogistic, analgesic, antipyretic parenteral preparation is disclosed comprising diclofenac, its salt, or both, a surfactant, cosurfactant, water, having a pH of 3-10, and optionally comprising an oily component, that can exhibit sustained therape... | 09/10/1996 |
| 5552433 | Method for lowering serum cholesterol A method of lowering serum cholesterol levels is disclosed comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## wherein R is herein defined; R1 is halo, C1 -C | 09/03/1996 |
| 5543409 | Indane derivatives for treating endotoxin shock and/or nephritis Disclosed are indane compounds represented by the formula: ##STR1## wherein R1 is aryl, lower alkyl, cycloalkyl, halogeno-lower alkyl, lower alkenyl, phenyl-substituted lower alkenyl, monocyclic or bicyclic aromatic heterocyclic having N, ... | 08/06/1996 |
| 5543434 | Nasal administration of ketamine to manage pain The invention relates to self-management of pain on an outpatient basis comprising administering via a nasal route a dose of ketamine effective to alleviate pain to a subject suffering from pain.... | 08/06/1996 |
| 5525596 | Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound Intestional absorption of zwitterionic compounds is enhanced when the compound is delivered with the absorption enhancer palmitoyl carnitine chloride and the solubilizing agent ଲ-cyclodextrin when compared to delivery with palmitoyl carnitine chlori... | 06/11/1996 |
| 5523402 | Tripyridyl macrocyclic compounds Tripyridyl macrocyclic compounds that are employed in the production of a complexing agent for use in targeting radioactive immunoreagents with the following formula are disclosed: ##STR1## wherein R1 represents hydrogen, alkyl, alkoxy, al... | 06/04/1996 |
| 5523318 | Pyrrolidino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents Pyrrolidinopyrazole-substituted oximes having the formula ##STR1## are disclosed wherein R1, R2, R3, R4, R5 and a are as described in the claims for the treatment of atherosclerosis and hyperchol... | 06/04/1996 |
| 5521172 | Methods for lowering serum cholesterol A method of lowering serum cholesterol levels comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## wherein R is as herein defined; R1 is halo, C1 -C6 a... | 05/28/1996 |
| 5516770 | Rapamycin formulation for IV injection Disclosed herein is an aqueous, injectable rapamycin solution, obtained by a process consisting of mixing 5 to 30 volume percent of a concentrate solution of rapamycin in propylene glycol, at concentrations of rapamycin ranging from 0.5 mg/ml to 10 mg/ml,... | 05/14/1996 |
| 5512587 | Method for treating opiate withdrawal A method is disclosed for treating opiate-addicted individuals to attentuate the withdrawal syndrome comprising administering the compound levamisole in a suitable pharmaceutical carrier.... | 04/30/1996 |
| 5512275 | Topical lotion and method for treatment of androgenic alopecia A formulation and method of treatment for androgenic alopecia wherein the active ingredient is liquor carbonis detergens, in combination with spirits of camphor, castor oil, isopropyl alcohol, and optionally salicyclic acid.... | 04/30/1996 |
| 5510354 | Imidazopyridine derivatives An imidazopyridine derivative of formula I! is disclosed ##STR1## wherein R1 is lower alkyl, R2 is a group of the formula ##STR2## Z is oxygen, R0 is a pyridyl, furyl or thienyl group, R3 is carboxyl ... | 04/23/1996 |
| 5506234 | ଲ-carboline derivatives for use as pharmaceutical agents ଲ-carbolines of formula I are described ##STR1## in which RA is a C6-12 aryl hetaryl as defined herein, that can be substituted singly to multiply with halogen, C1-4 -alkoxy, C1-4 -alkyl or amino, X i... | 04/09/1996 |
| 5506235 | Quinoline derivatives as immunostimulants This invention relates to compounds of the formula ##STR1## wherein R1, R2, R3, R4, R5, R6 and R7 are as defined hereinbelow that exhibit activity as immunostimulants.... | 04/09/1996 |
| 5500431 | Tetrahydro-ଲ-carbolines The present invention provides tetrahydro-betacarboline compounds having useful central nervous system activity.... | 03/19/1996 |
| 5498630 | Fungicides for the control of take-all disease of plants A method of controlling Take-All disease of plants by applying a fungicide of the formula ##STR1## wherein Z1 and Z2 are C and are part of an aromatic ring which is benzothiophene; and A is selected from --C(X)-amine wherein the amine is an unsubstit... | 03/12/1996 |
| 5492926 | Methods for inhibiting vascular smooth muscle cell proliferation and restinosis Methods of inhibiting vascular smooth muscle cell proliferation and vascular restinosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## wherein R1 and R... | 02/20/1996 |
| 5492915 | Substituted quinolyl compounds exhibiting selective leukotriene B4 antagonist activity This invention relates to compounds having selective LTB4 antagonist properties. Therapeutic compositions comprising said compounds and methods for the treatment of disorders involving LTB4 agonist-mediated activity utilizing said co... | 02/20/1996 |
| 5489600 | Piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis The present invention relates to piperidyl amides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.... | 02/06/1996 |
| 5488053 | Tetrahydro-pyrido-indole The present invention provides pentacyclic pyrido[3,4-b]indoles having useful central nervous system activity.... | 01/30/1996 |
| 5486624 | Kojic acid derivative Kojic acid derivatives of the following formula (I) ##STR1## where R is a hydrogen atom or methyl group, as radical scavengers and strong inhibitors of tyrosinase, an enzyme involved in a melanin formation.... | 01/23/1996 |
| 5484788 | Buspirone as a systemic immunosuppressant A method for suppressing an immune response in a mammal by systemically treating the mammal with an effective amount of buspirone that is capable of inhibiting classic contact hypersensitivity reactions.... | 01/16/1996 |
| 5484927 | Visible dye photosensitizers derived from tropinone Visible light absorbing dyes derived from tropinone are disclosed.... | 01/16/1996 |
| 5482950 | Methods for lowering serum cholesterol A method of lowering serum cholesterol levels comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## wherein R is hydrogen; hydroxy; C1 -C6 alkoxy; a group of the ... | 01/09/1996 |
| 5482948 | Pyridyl derivatives and pharmaceutical compositions comprising these compounds This invention relates to pyridyl derivatives of the formula ##STR1## wherein X, Y, A, n and R3 to R8 are defined hereinbelow, the enantiomers thereof, the cis- and trans-isomers thereof, which have antithrombotic pharmaceutical... | 01/09/1996 |
| 5480903 | 3,4-diarylchromans for inhibiting calmodulin activity A method for inhibiting is disclosed comprising administering, 3,4-diarylchromans and their pharmaceutically acceptable salts.... | 01/02/1996 |
| 5478829 | Solution of sparfloxacin, its preparation and salt of which it is composed This invention relates to a pharmaceutical composition comprising sparfloxacin and a stable aqueous solution of sparfloxacin of the formula (I): ##STR1## comprising sparfloxacin, one or more polyhydroxymonocarboxylic acids, or lactone derivative... | 12/26/1995 |
| 5475026 | Agent for treating hepatic diseases Beraprost, a agent for treating hepatic diseases, that is safe and chemically stable is disclosed.... | 12/12/1995 |
| 5475113 | Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity Compounds of the formula ##STR1## as herein defined, have retinoid-like activity and are substantially non-teratogenic and non-irritating to the skin.... | 12/12/1995 |
| 5475025 | Urea derivatives useful as platelet aggregation inhibitors Novel urea compounds are provided which inhibit platelet aggregation as well as pharmaceutical compositions and methods of using said compounds.... | 12/12/1995 |
| 5472959 | Carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace The invention relates to compounds of the formula ##STR1## wherein B1 and B2 are each independently hydrogen; hydroxy; --OR2 wherein R2 is a C1 -C4 alkyl or an Ar--Y group wherein Ar i... | 12/05/1995 |
| 5472983 | Benzamide-containing pharmaceutical compositions A group of benzamide compounds are disclosed that are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from neurodegenerative conditions associated with dopamine depletion.... | 12/05/1995 |
| 5470883 | Method of treating peripheral vasoconstriction with tamoxifen citrate A method of modifying peripheral vasoconstriction comprising administering a pharmacologically acceptable dose of tamoxifen.... | 11/28/1995 |
| 5470861 | Method of promoting hair growth The use of the compound 2-(6-cyano-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)pyridine-1-oxide represented by the formula ##STR1## as well as pharmaceutically acceptable salts, as topical agents to promote hair growth is disclosed.... | 11/28/1995 |
| 5468750 | Heterocycle-coupled substituted pyrrolo[3,2-c]pyridin-2-carboxylic acids A compound of formula ##STR1## in which A represents S; R1 is selected from the group consisting of OH, (C1 -C12)alkyl, (C1 -C12)alkoxy, benzyloxy, phenyl, benzyl (C1 -C4)al... | 11/21/1995 |
| 5462937 | Methods for inhibiting vascular smooth muscle cell proliferation and restinosis Methods of inhibiting vascular smooth muscle cell proliferation and restinosis are disclosed comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## wherein R1 | 10/31/1995 |
